| Literature DB >> 32214225 |
Cyril Legrand1, Roberto Saleppico1, Jana Sticht2,3, Fabio Lolicato1,4,5, Hans-Michael Müller1, Sabine Wegehingel1, Eleni Dimou1, Julia P Steringer1, Helge Ewers2, Ilpo Vattulainen4,5, Christian Freund2, Walter Nickel6.
Abstract
FGF2 is a tumor cell survival factor that is exported from cells by an ER/Golgi-independent secretory pathway. This unconventional mechanism of protein secretion is based on direct translocation of FGF2 across the plasma membrane. The Na,K-ATPase has previously been shown to play a role in this process, however, the underlying mechanism has remained elusive. Here, we define structural elements that are critical for a direct physical interaction between FGF2 and the α1 subunit of the Na,K-ATPase. In intact cells, corresponding FGF2 mutant forms were impaired regarding both recruitment at the inner plasma membrane leaflet and secretion. Ouabain, a drug that inhibits both the Na,K-ATPase and FGF2 secretion, was found to impair the interaction of FGF2 with the Na,K-ATPase in cells. Our findings reveal the Na,K-ATPase as the initial recruitment factor for FGF2 at the inner plasma membrane leaflet being required for efficient membrane translocation of FGF2 to cell surfaces.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32214225 PMCID: PMC7096399 DOI: 10.1038/s42003-020-0871-y
Source DB: PubMed Journal: Commun Biol ISSN: 2399-3642